[PDF] Top 20 HIGH DOSE ORAL BUSULFAN and INTRAVENOUS MELPHALAN AS CONDITIONING THERAPY for AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANT (HSCT) for the TREATMENT of PEDIATRIC SOLID TUMORS
Has 10000 "HIGH DOSE ORAL BUSULFAN and INTRAVENOUS MELPHALAN AS CONDITIONING THERAPY for AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANT (HSCT) for the TREATMENT of PEDIATRIC SOLID TUMORS" found on our website. Below are the top 20 most common "HIGH DOSE ORAL BUSULFAN and INTRAVENOUS MELPHALAN AS CONDITIONING THERAPY for AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANT (HSCT) for the TREATMENT of PEDIATRIC SOLID TUMORS".
HIGH DOSE ORAL BUSULFAN and INTRAVENOUS MELPHALAN AS CONDITIONING THERAPY for AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANT (HSCT) for the TREATMENT of PEDIATRIC SOLID TUMORS
... relapsed pediatric solid tumors usually have dis- mal prognosis and HSCT has been used as a treatment option for children with chemo-sensitive ...drugs and may have some degree ... See full document
1
HIGH DOSE CARBOPLATIN, ETOPOSIDE, MELPHALAN and AUTOLOGOUS HEMATOPOIETIC STEM CELL RESCUE WITH for the TREATMENT of RELAPSED PEDIATRIC GERM CELL TUMORS
... years. Stem cell sources for the msibs were marrow for 7 and PBSC for ...11. Conditioning regimen was fTBI based in 25, busulfan based in 15–of those, 5 were reduced ...A ... See full document
1
Autologous stem cell transplantation for the treatment of pediatric solid tumors in Brazil
... Sixty-three autologous HSCT were per- formed from August, 1994 to September, 2003; 80% of them were after ...(54%). The median age was 7 years (1 to 23). The underlying diagnoses were ... See full document
2
Viral infection is not uncommon in adult patients with severe hospital-acquired pneumonia.
... ICU of the Asan Medical Center, a tertiary referral hospital in Seoul, Republic of ...beds and eight ICUs. During the study period, most of the adult patients with severe ... See full document
11
Arq. NeuroPsiquiatr. vol.72 número6
... months and 10 who had suffered injury for more than 6 ...years, and their injuries were between C4-T10. The authors trans- planted autologous MSCs via lumbar ...in the MRI scans taken ... See full document
6
Rev. Bras. Hematol. Hemoter. vol.30 suppl.2
... increasing the dose of active drugs with shortening the time between cycles, resulting in dose-dense or dose-intense regimens; and 2) combining rituximab with ...in ... See full document
5
Rev. Bras. Hematol. Hemoter. vol.31 suppl.2
... Using the overall survival (OS), disease free survival (DFS) and progression free survival (PFS), as well as associated toxicity, the purpose of this work was to evaluate the ... See full document
6
Fusarium infection in hematopoietic stem cell transplant recipients
... characterize the epidemiology and prognostic factors of invasive fusariosis in hematopoietic stem cell transplant (HSCT) recipients, the records of HSCT ... See full document
6
Nursing care for hematopoietic stem cell transplant recipients and their families
... in the National Library of Medicine and 34 of these were included in the first selection, which con- sisted of reading the titles and abstracts, as they pre- sented ... See full document
8
Rev. Bras. Hematol. Hemoter. vol.31 suppl.2
... relapse and refractory patients, with acceptable toxicity, led to this drug being considered as a potential candidate to be used as maintenance after ...testing the potential role of thalidomide with ... See full document
2
Rev. Bras. Hematol. Hemoter. vol.35 número2
... vomiting and abdominal ...in the pancreatic body and tail, measuring ...IU/mL) and the carbohydrate antigen (CA) ...IU/mL) and no evidence of metastatic disease. As ... See full document
2
Rev. Bras. Hematol. Hemoter. vol.36 número4
... analyze the results of early hospital discharge on the treatment of patients submit- ted to autologous transplantation and the influence of nursing care on ... See full document
5
Rev. Bras. Hematol. Hemoter. vol.37 número6
... confirming the global importance of CDI in HSCT ...reports, the incidence of CDI observed in this study appears to be in the lower portion of the reported spectrum, ... See full document
2
Reconstituição imunológica após transplante autólogo de células-tronco hematopoéticas...
... As CTHs foram mobilizadas da medula óssea para o sangue periférico utilizando ciclofosfamida e fator estimulador de colônias granulocíticas (G-CSF, granulocyte-colony stimulating factor) (Leucin, Laboratory Bergamo, São ... See full document
147
QUALITY OF LIFE OF THE MAIN CARETAKERS OF POST- HEMATOPOIETIC STEM-CELL TRANSPLANT PATIENTS
... assess the existing correlation between the result of the SF-36 questionnaire and the Burden interview Scale, the results show posi- tive correlations for the ... See full document
10
Intensive chemotherapy as salvage treatment for solid tumors: focus on germ cell cancer
... plus autologous hematopoietic stem cell sup- port has been evaluated as part of first-line therapy by several studies ...recommended. The initial study hypothesis was not ... See full document
12
QUALITY OF LIFE OF THE MAIN CARETAKERS OF POST- HEMATOPOIETIC STEM-CELL TRANSPLANT PATIENTS
... cross-sectional and retrospective study carried out with 59 main caretakers of patients submitted to this treatment ...modality. The sociodemographic profile was characterized and ... See full document
10
Rev. Bras. Hematol. Hemoter. vol.39 número1
... anorexia and asthenia. The remaining patient’s history was ...history of smoking, alcohol or drug consumption and denied any history of systemic dis- ...history of gastric cancer ... See full document
4
A randomized, non-inferiority study comparing efficacy and safety of a single dose of pegfilgrastim versus daily filgrastim in pediatric patients after autologous peripheral blood stem cell transplant.
... by the working group for supportive care of the Italian Association of Pediatric Hematology Oncology (AIEOP) that was conducted in four transplant centres from May 2007 to June ... See full document
8
Effect of Annealing Time for Quenching CuAl7Fe5Ni5W2Si2 Bronze on the Microstructure and Mechanical Properties
... scale of temperature and time (Fig. 9) it is difficult to identify the characteristic changes of the sample temperature, respectively, during the annealing (stage T2 - isothermal ... See full document
18
temas relacionados